A Multicenter, Double-Blind, Phase III, Adjuvant-Controlled Study of the Effect of 10 Units of HIV-1 Immunogen (Remune) Compared to Incomplete Freund's Adjuvant (IFA) Alone Every 12 Weeks on AIDS-Free Survival in Subjects With HIV Infection and CD4 T-Lymphocytes Between 300 and 549 Cells/microL Rega

PHASE3CompletedINTERVENTIONAL
Enrollment

3,000

Participants

Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
BIOLOGICAL

HIV-1 Immunogen

Trial Locations (54)

10016

Anderson Clinical Research, New York

10019

St Luke's - Roosevelt Hosp Ctr / Div of Infect Dis, New York

10021

Cornell Univ Med College, New York

10029

Mount Sinai Med Ctr, New York

10031

Dr Barbara Justice, New York

10456

Bronx Lebanon Hosp Ctr, The Bronx

14620

Community Health Network, Rochester

15218

Anderson Clinical Research, Pittsburgh

19146

The Graduate Hosp, Philadelphia

20009

Whitman Walker Clinic Inc, Washington D.C.

20037

Anderson Clinical Research, Washington D.C.

George Washington Univ Med Ctr, Washington D.C.

22003

Infectious Disease Physicians Inc, Annandale

23507

Eastern Virginia Med School, Norfolk

23666

Hampton Roads Med Specialists, Hampton

28207

Nalle Clinic, Charlotte

29425

Med Univ of South Carolina, Charleston

30308

AIDS Research Consortium of Atlanta, Atlanta

33140

Ctr for Special Immunology, Miami Beach

33179

The Coleman Institute, North Miami

33316

North Broward Hosp District, Fort Lauderdale

33617

Clinical Pharmacology Services, Tampa

37212

Vanderbilt Univ Med Ctr, Nashville

40536

Univ of Kentucky / Division of ID Research, Lexington

43210

Ohio State Univ / Division of Infectious Disease, Columbus

45267

Univ of Cincinnati Med Ctr / Holmes Division, Cincinnati

46219

Community Hosp Indianapolis, Indianapolis

48201

Wayne State Univ / WSU / DMC HIV / AIDS Program, Detroit

48202

Henry Ford Hosp / Infectious Diseases, Detroit

53203

Wisconsin AIDS Research Consortium, Milwaukee

55407

Abbott Northwestern Hosp, Minneapolis

60612

Rush Med Ctr, Chicago

60657

Chicago AIDS Research Alliance, Chicago

Ctr for Special Immunology, Chicago

63108

Washington Univ / St Louis Connect Care, St Louis

64111

Kansas City AIDS Research Consortium, Kansas City

67214

UKSM-W Med Practice Association, Wichita

73117

Univ of Oklahoma, Oklahoma City

75235

Metroplex Clinical Research Ctr, Dallas

77027

ONCOL Med Associates / PA, Houston

77555

Univ of Texas Med Branch Ctr for Clinical Studies, Galveston

84108

Univ of Utah Med School / Clinical Trials Ctr, Salt Lake City

85016

Phoenix Body Positive, Phoenix

90028

Jeffrey Goodman Special Care Clinic, Los Angeles

90036

Kraus Med Partners, Los Angeles

90048

Cedars Sinai Med Ctr, Los Angeles

92718

Ctr for Special Immunology, Irvine

94063

AIDS Community Research Consortium, Redwood City

97210

The Research and Education Group, Portland

98104

Novum Inc, Seattle

02210

JSI Research and Training Institute, Boston

02445

Community Research Initiative of New England, Brookline Village

01040

Providence Mercy Hosp, Holyoke

02860

Mem Hosp of Rhode Island, Pawtucket

All Listed Sponsors
lead

The Immune Response Corporation

INDUSTRY

NCT00002359 - A Multicenter, Double-Blind, Phase III, Adjuvant-Controlled Study of the Effect of 10 Units of HIV-1 Immunogen (Remune) Compared to Incomplete Freund's Adjuvant (IFA) Alone Every 12 Weeks on AIDS-Free Survival in Subjects With HIV Infection and CD4 T-Lymphocytes Between 300 and 549 Cells/microL Rega | Biotech Hunter | Biotech Hunter